Story highlights Unlike other flu vaccines, Flublok doesn't rely on eggs or the influenza virus

Instead, it's made by growing a virus protein in insect cells

This allows for more rapid production in the event of a pandemic, the FDA says

The vaccine is available in limited supplies during the current flu season

As flu season rages across the United States, federal regulators say they have approved a new kind of vaccine for the virus.

The new product, Flublok, which is available in limited supplies for the current season, is different from other flu vaccines, because it isn't made using eggs or an influenza virus, the Food and Drug Administration said Wednesday.

Instead, Flublok's production involves programming insect cells grown in steel tanks to produce large amounts of a particular flu virus protein, known as hemagglutinin, according to Protein Sciences, the vaccine's manufacturer

Most human antibodies that fight flu infection are directed against hemagglutinin, the FDA said.

This method allows for more rapid production, making more of the vaccine available more quickly in the event of a pandemic, the FDA said.

"This approval represents a technological advance in the manufacturing of an influenza vaccine," said Karen Midthun, director of the FDA's Center for Biologics Evaluation and Research.

Flublok, which is different from other flu vaccines, because it isn't made using eggs or an influenza virus, is approved only for adults ages 18 - 49.

It has already been used in vaccines approved for other infectious diseases.

Flublok is approved only for adults ages 18 - 49.

Manufacturers said there was plenty of vaccine for those who want to get a flu shot. But there have been reports of spot shortages, Frieden said.

JUST WATCHED Inside a flu vaccine lab Replay More Videos ... MUST WATCH Inside a flu vaccine lab 02:31

JUST WATCHED Flu fear goes to Hollywood Replay More Videos ... MUST WATCH Flu fear goes to Hollywood 02:08

Flublok will be available in limited supply this winter and widely available during the next flu season, said Protein Sciences, which is based in Meriden, Connecticut.

Flublok contains the elements necessary to help fend off three different flu strains, including H1N1 and H3N2, the regulator said.

And it proved 44.6% effective against all influenza strains in circulation, not just those that matched the strains included in the vaccine, according to the FDA.